Comparison of single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection: A phase III randomized, double-blind study

Trial Profile

Comparison of single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection: A phase III randomized, double-blind study

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Oct 2014

At a glance

  • Drugs Peramivir (Primary) ; Oseltamivir
  • Indications Influenza virus infections
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 08 Aug 2011 Status changed from active, no longer recruiting to completed.
    • 26 Feb 2010 The results of this trial supported the approval of peramivir in Japan for the treatment of influenza virus infection.
    • 12 Sep 2009 Results have been reported at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top